PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Todd Werpy, ADM to Keynote Present at Biobased Chemicals Conference on September 16-17 in San Francisco, California - Todd Werpy, Vice President of ADM, will give a keynote presentation “Toward a New Generation of Renewable Fuels and Chemicals” at the 4th Biobased Chemicals: Commercialization & Partnering Conference on September 16-17 in San Francisco, CA
Todd Werpy, ADM to Keynote Present at Biobased Chemicals Conference on September 16-17 in San Francisco, California

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2013/05/23 - Todd Werpy, Vice President of ADM, will give a keynote presentation “Toward a New Generation of Renewable Fuels and Chemicals” at the 4th Biobased Chemicals: Commercialization & Partnering Conference on September 16-17 in San Francisco, CA.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In this presentation, Dr. Todd Werpy will offer an overview of ADM’s biofuel research partnerships, discuss some of the pilot projects under way, and describe the company’s efforts to develop both direct, drop-in replacements for commonly used chemicals as well as novel chemicals made from bio-advantaged molecules.

As one of the world's largest agricultural processors, Archer Daniels Midland Company (ADM) connects the harvest to the home to meet the vital food and energy needs of a growing global population. The same operations that enable ADM to produce hundreds of food ingredients from farmers’ crops also provide it with the scale and expertise to efficiently produce renewable fuels and chemicals. As Vice President of Research & Development at ADM, Dr. Werpy is responsible for overseeing ADM’s efforts to expand its product portfolio and strengthening research partnership with government agencies, academic institutions and corporations. Werpy developed the catalytic technology being commercialized by ADM for the conversion of glycerin and sorbitol to propylene glycol. He holds 20 patents in the area of catalysis and chemical conversion of biomass to chemicals.

The 4th Biobased Chemicals: Commercialization & Partnering Conference will look to examine new supply chain developments and business models being adopted for biobased chemicals products. Topics include novel chemical production platforms, advantageous feedstock, end user applications, consumer products and packaging applications, securing funding and strategic partnerships, trends and challenges in commercial scale up, and what’s hot in venture capital. Renewable chemical companies, biofuel companies and end market consumers will be discussing innovations in the science, technology and end-market development of biobased chemicals, polymers and plastics. Get the latest updates from investment, scientific, manufacturer and business perspectives - the highlights and the challenges to making big new things happen with special emphasis on commercialization!

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Todd Werpy, ADM to Keynote Present at Biobased Chemicals Conference on September 16-17 in San Francisco, California

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Deb Sheppard - Medium Psychic Author Speaker





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)